Who Buys Brufen from India — 447 Importers Behind a $4.5M Market

The 447 buyers of Brufen from India can be categorized into several segments:

1. Distributors: Entities like BGP PRODUCTS GMBH and ALLOGA (NEDERLAND) B.V., both based in the Netherlands, function as intermediaries, purchasing Brufen in bulk and supplying it to various healthcare providers. Their substantial purchase volumes indicate a focus on broad market distribution.

2. Hospital Groups: Organizations such as SUNSHINE HEALTHCARE LANKA LIMITED in Sri Lanka likely procure Brufen to meet the analgesic needs of their patient populations. Their purchasing patterns are typically consistent, aligning with patient demand and treatment protocols.

3. Retail Chains: While specific retail chains are not identified in the top buyers, such entities generally procure Brufen to stock their pharmacies, ensuring availability for over-the-counter sales. Their orders are influenced by consumer demand and inventory turnover rates.

4. Government Procurement: National health departments or agencies may engage in bulk purchasing of Brufen through tenders to supply public healthcare facilities. These procurements are often periodic and substantial, aiming to meet public health needs efficiently.

5. Re-exporters: Some buyers may act as re-exporters, importing Brufen from India to distribute it to other countries, leveraging trade agreements or logistical advantages. Their purchasing behavior is driven by international market demands and trade policies.

6. Contract Manufacturers: Entities that import Brufen for incorporation into their own branded products or formulations. Their procurement is aligned with production schedules and market demand for their finished products.

For the top five importing countries, the import regulations for Brufen (HS Code: 30049063) are as follows:

The demand for Brufen in importing countries is influenced by several factors:

1. Disease Prevalence: Brufen, known for its analgesic and anti-inflammatory properties, is widely used to manage conditions such as arthritis, musculoskeletal disorders, and postoperative pain. The prevalence of these conditions drives consistent demand for the medication.

2. Government Healthcare Programs: Many countries have national health programs that include the provision of essential medicines like Brufen. For instance, the inclusion of ibuprofen in the WHO Model List of Essential Medicines underscores its importance in basic healthcare.

3. Universal Health Coverage Expansion: As nations strive to achieve universal health coverage, the accessibility and affordability of essential medicines become paramount. This expansion often leads to increased procurement of medications like Brufen to meet the healthcare needs of the population.

4. WHO Essential Medicines List Procurement: The WHO's Model List of Essential Medicines serves as a guide for countries to develop their own national lists, ensuring the availability of fundamental treatments. Brufen's presence on this list facilitates its procurement and distribution in various healthcare settings.

5. Tender-Based Purchasing: Public sector procurement often utilizes tender systems to acquire medicines efficiently. The operational principles for good pharmaceutical procurement emphasize limiting procurement to essential medicines lists and using international nonproprietary names, which aligns with Brufen's procurement practices.

With 447 buyers across 78 countries, the global reach and consistent demand for Brufen highlight its critical role in pain management and inflammation control worldwide.

The 447 buyers of Brufen from India can be categorized into several segments:

1. Distributors: Entities like BGP PRODUCTS GMBH and ALLOGA (NEDERLAND) B.V., both based in the Netherlands, function as intermediaries, purchasing Brufen in bulk and supplying it to various healthcare providers. Their substantial purchase volumes indicate a focus on broad market distribution.

2. Hospital Groups: Organizations such as SUNSHINE HEALTHCARE LANKA LIMITED in Sri Lanka likely procure Brufen to meet the analgesic needs of their patient populations. Their purchasing patterns are typically consistent, aligning with patient demand and treatment protocols.

3. Retail Chains: While specific retail chains are not identified in the top buyers, such entities generally procure Brufen to stock their pharmacies, ensuring availability for over-the-counter sales. Their orders are influenced by consumer demand and inventory turnover rates.

4. Government Procurement: National health departments or agencies may engage in bulk purchasing of Brufen through tenders to supply public healthcare facilities. These procurements are often periodic and substantial, aiming to meet public health needs efficiently.

5. Re-exporters: Some buyers may act as re-exporters, importing Brufen from India to distribute it to other countries, leveraging trade agreements or logistical advantages. Their purchasing behavior is driven by international market demands and trade policies.

6. Contract Manufacturers: Entities that import Brufen for incorporation into their own branded products or formulations. Their procurement is aligned with production schedules and market demand for their finished products.

For the top five importing countries, the import regulations for Brufen (HS Code: 30049063) are as follows:

The demand for Brufen in importing countries is influenced by several factors:

1. Disease Prevalence: Brufen, known for its analgesic and anti-inflammatory properties, is widely used to manage conditions such as arthritis, musculoskeletal disorders, and postoperative pain. The prevalence of these conditions drives consistent demand for the medication.

2. Government Healthcare Programs: Many countries have national health programs that include the provision of essential medicines like Brufen. For instance, the inclusion of ibuprofen in the WHO Model List of Essential Medicines underscores its importance in basic healthcare.

3. Universal Health Coverage Expansion: As nations strive to achieve universal health coverage, the accessibility and affordability of essential medicines become paramount. This expansion often leads to increased procurement of medications like Brufen to meet the healthcare needs of the population.

4. WHO Essential Medicines List Procurement: The WHO's Model List of Essential Medicines serves as a guide for countries to develop their own national lists, ensuring the availability of fundamental treatments. Brufen's presence on this list facilitates its procurement and distribution in various healthcare settings.

5. Tender-Based Purchasing: Public sector procurement often utilizes tender systems to acquire medicines efficiently. The operational principles for good pharmaceutical procurement emphasize limiting procurement to essential medicines lists and using international nonproprietary names, which aligns with Brufen's procurement practices.

With 447 buyers across 78 countries, the global reach and consistent demand for Brufen highlight its critical role in pain management and inflammation control worldwide.